1 day Ago By ABMN Staff
Healthpeak Properties ( NYSE:DOC – Get Free Report ) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Tuesday. Other analysts also recently issued reports about the stock.
Wedbush boosted their price target on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research note on Monday, July 29th.
Wells Fargo & Company raised Healthpeak Properties to a “hold” rating in a research note on Monday, August 12th. Citigroup raised their price target on Healthpeak Properties from $20.00 to $22.
00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. Evercore ISI boosted their price objective on Healthpeak Properties from $25.00 to $26.
00 and gave the company an “outperform” rating in a research report on Monday. Finally, Scotiabank raised their target price on shares of Healthpeak Properties from $23.00 to $24.
00 and gave the stock a “sector outperform” rating in a report on Monday, September 9th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $21.
83. Get Our Latest Stock Analysis on Healthpeak Properties Healthpeak Properties Price Performance Healthpeak Properties ( NYSE:DOC – Get Free Report ) last issued its quarterly earnings results on Thursday, July 25th. The real estate investment trust reported $0.
21 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23).
The business had revenue of $695.50 million for the quarter, compared to the consensus estimate of $665.11 million.
Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%.
The firm’s revenue was up 27.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.
45 earnings per share. Sell-side analysts forecast that Healthpeak Properties will post 1.8 EPS for the current fiscal year.
Hedge Funds Weigh In On Healthpeak Properties Hedge funds and other institutional investors have recently modified their holdings of the stock. Norges Bank bought a new stake in Healthpeak Properties during the 4th quarter valued at approximately $34,883,000. Isthmus Partners LLC boosted its position in shares of Healthpeak Properties by 11.
0% during the fourth quarter. Isthmus Partners LLC now owns 639,633 shares of the real estate investment trust’s stock valued at $8,514,000 after purchasing an additional 63,493 shares in the last quarter. UBS Group AG grew its stake in Healthpeak Properties by 56.
5% in the fourth quarter. UBS Group AG now owns 526,676 shares of the real estate investment trust’s stock worth $7,010,000 after purchasing an additional 190,186 shares during the period. Angelo Gordon & CO.
L.P. bought a new position in Healthpeak Properties in the fourth quarter worth $3,713,000.
Finally, Nomura Asset Management Co. Ltd. lifted its position in Healthpeak Properties by 2.
9% during the fourth quarter. Nomura Asset Management Co. Ltd.
now owns 269,310 shares of the real estate investment trust’s stock valued at $3,585,000 after buying an additional 7,500 shares during the period. Hedge funds and other institutional investors own 93.57% of the company’s stock.
Healthpeak Properties Company Profile ( Get Free Report ) Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. Further Reading Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.
com's FREE daily email newsletter ..
